Injectable Bromelain Solution (IBS) is a modified investigational derivate of the medical grade bromelain-debriding pharmaceutical agent (NexoBrid) studied and approved for a rapid (four-hour single application), eschar-specific, deep burn debridement. We conducted an Specially prepared medical grade IBS was injected into fresh Dupuytren’s cords excised from patients undergoing surgical fasciectomy. These cords were tested by tension-loading them to failure with the Zwick 1445 (Zwick GmbH & Co. KG, Ulm, Germany) tension testing system.Objectives
Materials and Methods
Injectable collagenase is an alternative to surgical
treatment for Dupuytren’s disease. Previous studies have reported
on the effectiveness of collagenase in finger contractures. This
prospective study reports on the short-term safety and efficacy
of collagenase treatment in five thumb and first web space Dupuytren’s
contractures. The thumb and first web space contractures were treated
with injectable collagenase in four consecutive patients (five hands) with
experience of previous surgical digital fasciectomy. The thumb contracture
was measured by angle and span in two planes of thumb extension
and abduction before injection and after manipulation. Collagenase
treatment resulted in release of the contracture with a mean increase
in thumb to index angle from 23° (10° to 35°) to 56° (45° to 60°)
in extension and from 30° (10° to 50°) to 58° (50° to 65°) in abduction
and a mean increase in span from 1.9 cm (1 to 3.5) to 3.9 cm (3
to 5) in extension and from 2.4 cm (1.5 to 3.5) to 3.9 cm (3 to
4.5) in abduction. All patients reported an increased range of movement
and function and described collagenase therapy as preferable to
surgery. In the short-term collagenase is an effective, well-tolerated
and safe alternative to surgery for Dupuytren’s disease of the thumb.
